beclometasonia

Beclometasone, also spelled beclomethasone, is a synthetic corticosteroid used to treat inflammatory conditions. It belongs to the glucocorticoid class and works by activating intracellular glucocorticoid receptors, which reduces the production of inflammatory mediators and the activity of immune cells. This anti-inflammatory effect helps alleviate symptoms such as swelling, redness, and narrowing of airways.

Forms and indications: Inhaled beclometasone dipropionate is prescribed for maintenance therapy in persistent asthma and can be used as part of a larger asthma management plan. Nasal beclometasone sprays are used for allergic rhinitis and nasal inflammation. Topical preparations containing beclometasone are used for dermatologic conditions such as eczema and dermatitis, where localized anti-inflammatory action is desired.

Pharmacokinetics and safety: Inhaled, nasal, and topical forms are designed to minimize systemic absorption, but some amount may enter the bloodstream. Metabolism occurs mainly in the liver, and excretion is through the bile and urine. Local adverse effects are common and include throat irritation, hoarseness, coughing, and oral candidiasis with inhaled forms; nasal sprays may cause irritation or dryness; topical use can lead to skin thinning or irritation. Systemic effects are uncommon at standard doses but can occur with long-term high-dose use, especially in children, and may include growth suppression or adrenal suppression. Beclometasone should be avoided in active fungal infections and used with caution during pregnancy and lactation when benefits outweigh risks.

Availability: Beclometasone is available in various countries in inhaled, nasal, and topical formulations, typically by prescription. Its clinical use relies on dosing, formulation, and individual patient factors to balance efficacy and safety.